Effective oral PrEP limits the additional price payers should be willing to pay for long-acting injectable PrEP, say researchers.
Departments, Centers, & Programs:
Mass General Infectious Diseases
55 Fruit St.
Boston, MA 02114
- MD, Harvard Medical School
- Residency, Beth Israel Deaconess Medical Center
- Fellowship, Beth Israel Deaconess Medical Center
American Board Certifications
- Internal Medicine, American Board of Internal Medicine
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Freedberg's research interests focus on HIV, TB, as well as other chronic disease clinical outcomes and health policy, utilizing the methods of comparative effectiveness, cost-effectiveness analysis, clinical epidemiology, and implementation science. He is most interested in the intersection of clinical medicine and economics - to understand the "value" of health care.
His current research efforts are focused in the United States, France, Portugal, Brazil, South Africa, Cote d'Ivoire, Zimbabwe, Botswana, Mozambique and India. This NIH and foundation-funded work examines clinical policies for antiretroviral use, HIV testing, laboratory management, and HIV/TB co-infection.
The Medical Practice Evaluation Center team has a particular interest in informing guidelines in individual countries and across regions in both well-resourced and resource-limited settings. Collaborators include investigators in each of the countries above, as well as in HIV trials groups in the United States including the ACTG, IMPAACT, and the HPTN.